Cargando…

Evaluating Global Health Partnerships: A Case Study of a Gavi HPV Vaccine Application Process in Uganda

Background: Global health partnerships have grown rapidly in number and scope, yet there has been less emphasis on their evaluation. Gavi, the Vaccine Alliance, is one such public-private partnership; in Gavi-eligible countries partnerships are dynamic networks of immunization actors who work togeth...

Descripción completa

Detalles Bibliográficos
Autores principales: Kamya, Carol, Shearer, Jessica, Asiimwe, Gilbert, Carnahan, Emily, Salisbury, Nicole, Waiswa, Peter, Brinkerhoff, Jennifer, Hozumi, Dai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kerman University of Medical Sciences 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5458794/
https://www.ncbi.nlm.nih.gov/pubmed/28812825
http://dx.doi.org/10.15171/ijhpm.2016.137
_version_ 1783241823707201536
author Kamya, Carol
Shearer, Jessica
Asiimwe, Gilbert
Carnahan, Emily
Salisbury, Nicole
Waiswa, Peter
Brinkerhoff, Jennifer
Hozumi, Dai
author_facet Kamya, Carol
Shearer, Jessica
Asiimwe, Gilbert
Carnahan, Emily
Salisbury, Nicole
Waiswa, Peter
Brinkerhoff, Jennifer
Hozumi, Dai
author_sort Kamya, Carol
collection PubMed
description Background: Global health partnerships have grown rapidly in number and scope, yet there has been less emphasis on their evaluation. Gavi, the Vaccine Alliance, is one such public-private partnership; in Gavi-eligible countries partnerships are dynamic networks of immunization actors who work together to support all stages and aspects of Gavi support. This paper describes a conceptual framework – the partnership framework – and analytic approach for evaluating the perceptions of partnerships’ added value as well as the results from an application to one case in Uganda. Methods: We used a mixed-methods case study design embedded in the Gavi Full Country Evaluations (FCE) to test the partnership framework on Uganda’s human papillomavirus (HPV) vaccine application partnership. Data from document review, interviews, and social network surveys enabled the testing of the relationships between partnership framework domains (context, structure, practices, performance, and outcomes). Topic guides were based on the framework domains and network surveys identified working together relationships, professional trust, and perceptions of the effectiveness, efficiency, and legitimacy of the partnership’s role in this process. Results: Data from seven in-depth interviews, 11 network surveys and document review were analyzed according to the partnership framework, confirming relationships between the framework domains. Trust was an important contributor to the perceived effectiveness of the process. The network was structured around the EPI program, who was considered the leader of this process. While the structure and composition of the network was largely viewed as supporting an effective and legitimate process, the absence of the Ministry of Education (MoE) may have had downstream consequences if this study’s results had not been shared with the Ministry of Health (MoH) and acted upon. The partnership was not perceived to have increased the efficiency of the process, perhaps as a result of unclear or absent guidelines around roles and responsibilities. Conclusion: The health and functioning of global health partnerships can be evaluated using the framework and approach presented here. Network theory and methods added value to the conceptual and analytic processes and we recommend applying this approach to other global health partnerships to ensure that they are meeting the complex challenges they were designed to address.
format Online
Article
Text
id pubmed-5458794
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Kerman University of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-54587942017-06-08 Evaluating Global Health Partnerships: A Case Study of a Gavi HPV Vaccine Application Process in Uganda Kamya, Carol Shearer, Jessica Asiimwe, Gilbert Carnahan, Emily Salisbury, Nicole Waiswa, Peter Brinkerhoff, Jennifer Hozumi, Dai Int J Health Policy Manag Original Article Background: Global health partnerships have grown rapidly in number and scope, yet there has been less emphasis on their evaluation. Gavi, the Vaccine Alliance, is one such public-private partnership; in Gavi-eligible countries partnerships are dynamic networks of immunization actors who work together to support all stages and aspects of Gavi support. This paper describes a conceptual framework – the partnership framework – and analytic approach for evaluating the perceptions of partnerships’ added value as well as the results from an application to one case in Uganda. Methods: We used a mixed-methods case study design embedded in the Gavi Full Country Evaluations (FCE) to test the partnership framework on Uganda’s human papillomavirus (HPV) vaccine application partnership. Data from document review, interviews, and social network surveys enabled the testing of the relationships between partnership framework domains (context, structure, practices, performance, and outcomes). Topic guides were based on the framework domains and network surveys identified working together relationships, professional trust, and perceptions of the effectiveness, efficiency, and legitimacy of the partnership’s role in this process. Results: Data from seven in-depth interviews, 11 network surveys and document review were analyzed according to the partnership framework, confirming relationships between the framework domains. Trust was an important contributor to the perceived effectiveness of the process. The network was structured around the EPI program, who was considered the leader of this process. While the structure and composition of the network was largely viewed as supporting an effective and legitimate process, the absence of the Ministry of Education (MoE) may have had downstream consequences if this study’s results had not been shared with the Ministry of Health (MoH) and acted upon. The partnership was not perceived to have increased the efficiency of the process, perhaps as a result of unclear or absent guidelines around roles and responsibilities. Conclusion: The health and functioning of global health partnerships can be evaluated using the framework and approach presented here. Network theory and methods added value to the conceptual and analytic processes and we recommend applying this approach to other global health partnerships to ensure that they are meeting the complex challenges they were designed to address. Kerman University of Medical Sciences 2016-10-26 /pmc/articles/PMC5458794/ /pubmed/28812825 http://dx.doi.org/10.15171/ijhpm.2016.137 Text en © 2017 The Author(s); Published by Kerman University of Medical Sciences This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Kamya, Carol
Shearer, Jessica
Asiimwe, Gilbert
Carnahan, Emily
Salisbury, Nicole
Waiswa, Peter
Brinkerhoff, Jennifer
Hozumi, Dai
Evaluating Global Health Partnerships: A Case Study of a Gavi HPV Vaccine Application Process in Uganda
title Evaluating Global Health Partnerships: A Case Study of a Gavi HPV Vaccine Application Process in Uganda
title_full Evaluating Global Health Partnerships: A Case Study of a Gavi HPV Vaccine Application Process in Uganda
title_fullStr Evaluating Global Health Partnerships: A Case Study of a Gavi HPV Vaccine Application Process in Uganda
title_full_unstemmed Evaluating Global Health Partnerships: A Case Study of a Gavi HPV Vaccine Application Process in Uganda
title_short Evaluating Global Health Partnerships: A Case Study of a Gavi HPV Vaccine Application Process in Uganda
title_sort evaluating global health partnerships: a case study of a gavi hpv vaccine application process in uganda
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5458794/
https://www.ncbi.nlm.nih.gov/pubmed/28812825
http://dx.doi.org/10.15171/ijhpm.2016.137
work_keys_str_mv AT kamyacarol evaluatingglobalhealthpartnershipsacasestudyofagavihpvvaccineapplicationprocessinuganda
AT shearerjessica evaluatingglobalhealthpartnershipsacasestudyofagavihpvvaccineapplicationprocessinuganda
AT asiimwegilbert evaluatingglobalhealthpartnershipsacasestudyofagavihpvvaccineapplicationprocessinuganda
AT carnahanemily evaluatingglobalhealthpartnershipsacasestudyofagavihpvvaccineapplicationprocessinuganda
AT salisburynicole evaluatingglobalhealthpartnershipsacasestudyofagavihpvvaccineapplicationprocessinuganda
AT waiswapeter evaluatingglobalhealthpartnershipsacasestudyofagavihpvvaccineapplicationprocessinuganda
AT brinkerhoffjennifer evaluatingglobalhealthpartnershipsacasestudyofagavihpvvaccineapplicationprocessinuganda
AT hozumidai evaluatingglobalhealthpartnershipsacasestudyofagavihpvvaccineapplicationprocessinuganda